CMT & COVID-19

Our mission is to increase awareness and accurate diagnosis of Charcot-Marie-Tooth (CMT) and related inherited neuropathies, support patients and families living with CMT, and fund research that will lead to treatments and cures.

Patients

Medical Professionals

Research/Industry

Get Involved

Your Voices Were HEARD: Watch HNF’s Externally-led Patient-Focused Drug Development Meeting ~ Click Here

Latest News From HNF

HEREDITARY NEUROPATHY FOUNDATION (HNF) IS HERE FOR YOU DURING THIS TIME OF UNCERTAINTY

As you know, HNF is monitoring the COVID-19 situation as it continues. Along with other organizations worldwide, we have postponed all in person events through the end of July and will continue to assess future in-person events, as necessary. The HNF team...

New Board Member, Lisa McCarthy

Through their decades-long friendship, Lisa was inspired by HNF's Founder/CEO Allison’s resilience and drive to help the CMT community live full lives and find a cure. After leading a Fast Forward session at the 2018 HNF Summit, Lisa felt compelled to get more...

Novel findings of a new common type of CMT2 that might be the 1st step to a treatment: SORD gene deficiency, the most common autosomal-recessive type of CMT

Dr. Stephan Züchner and colleagues at the University of Miami (Drs. Andrea Cortese, Grace Zhai, Andriana Rebelo), along with the Inherited Neuropathies Consortium (INC) – a group of CMT academic experts led by Dr. Michael Shy at the University of Iowa – has...

CMT & COVID-19 FAQ WITH DR. BACH

Respiratory weakness is only recently being acknowledged as a symptom of CMT so there is still a lot that we as patients need to learn regarding standard of care so that we (and our loved ones) can be our best advocates. Having CMT doesn’t necessarily put you in the...

Painting By Mouth – Kaileen Selig

CMT doesn’t stop artist, Kaileen Selig from painting beautiful pieces using her mouth.

Get Involved

Here's How!